Minaris Advanced Therapies
Gretchen O. is a seasoned professional with extensive experience in Quality Assurance within the advanced therapies and biopharmaceutical sectors. Currently serving as a Senior QA Specialist Testing/Compliance at Minaris Advanced Therapies since May 2025, Gretchen previously held similar roles at Advanced Therapies, LLC, where significant contributions included the initiation of a QA Testing Process Mapping Project and the development of GDP training. Prior experience at WuXi AppTec involved enhancing QA training consistency and efficiently managing daily QA metrics. Starting in quality assurance with the American Red Cross, Gretchen improved proficiency testing processes and received recognition for exceptional performance. An academic background includes a Master of Science in Environmental Health and a Bachelor of Science in Natural Sciences from the University of Puerto Rico.
This person is not in any teams
This person is not in any offices
Minaris Advanced Therapies
1 followers
Minaris Advanced Therapies is a global contract development and manufacturing organization (CDMO) and contract testing provider focused exclusively on cell and gene therapies. Minaris Advanced Therapies is headquartered in Philadelphia, Pennsylvania, and has more than 730,000 square feet of infrastructure across the United States, Europe and Asia. We have manufactured and released over 7,500 GMP batches and our global network supports therapy developers through early-stage development, clinical trials and commercial manufacturing. By combining scientific expertise with best-in-class manufacturing and testing services, we help bring safe, effective therapies to patients faster and more efficiently. With more than 20 years’ experience in the field of regenerative medicine, we are trusted partner ensuring scalability, delivering high quality results, and achieving cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies. Minaris Advanced Therapies is wholly owned by Altaris, LLC.